Ingevity Corporation

Ingevity Corporation (NGVT) Market Cap

Ingevity Corporation has a market capitalization of $2.65B.

Financials based on reported quarter end 2025-12-31

Price: $75.20

1.46 (1.98%)

Market Cap: 2.65B

NYSE · time unavailable

CEO: David H. Li

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 2016-05-03

Website: https://www.ingevity.com

Ingevity Corporation (NGVT) - Company Information

Market Cap: 2.65B · Sector: Basic Materials

Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Analyst Sentiment

79%
Strong Buy

Based on 4 ratings

Analyst 1Y Forecast: $71.67

Average target (based on 2 sources)

Consensus Price Target

Low

$65

Median

$82

High

$83

Average

$77

Potential Upside: 2.0%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 INGEVITY CORP (NGVT) — Investment Overview

🧩 Business Model Overview

Ingevity Corporation (NYSE: NGVT) is a global specialty chemicals company that leverages its expertise in engineered chemistries derived predominantly from renewables-based feedstocks. Headquartered in the United States, Ingevity operates through two principal business segments: Performance Materials and Performance Chemicals. The company’s products are integral in diverse markets, including automotive, pavement, lubricants, oil exploration, agriculture, and adhesives, serving a roster of blue-chip customers and industrial end-markets. Ingevity's operations encompass manufacturing, research and development, and an extensive technical service network. The company transforms renewable raw materials like pine chemicals and activated carbon into value-added solutions that enhance the performance, efficiency, and sustainability of customers’ finished products.

💰 Revenue Streams & Monetisation Model

Ingevity’s revenue generation is rooted in its two major business segments:
  • Performance Materials: This division primarily manufactures activated carbon products, which are essential components in gasoline vapor emission control systems mandated by automotive regulations. The majority of the Performance Materials revenue is derived from long-term supply agreements with global automotive original equipment manufacturers (OEMs) and Tier 1 suppliers. These solutions are critical for compliance with environmental standards and demonstrate high customer retention rates due to rigorous qualification processes and regulatory dependencies.
  • Performance Chemicals: This segment produces specialty chemicals, including adhesives, asphalt additives, lubricants, oilfield chemicals, and agrochemical intermediates. Revenue stems from both long-term contracts and spot sales to industrial customers, government entities, and global distributors. Specialty formulations often command premium pricing due to their tailored properties and contribution to customer process optimization.
The company’s monetisation model centers on value-added, high-margin solutions, supported by technical service and custom formulation capabilities. Strong relationships with OEMs, and a focus on regulatory-driven demand in automotive and infrastructure, underpin recurring revenues.

🧠 Competitive Advantages & Market Positioning

Ingevity benefits from several structural competitive advantages:
  • Technical Barriers to Entry: Its products, particularly activated carbons and specialty pine chemicals, require proprietary production know-how, significant capital investment, and stringent quality validation, especially for automotive applications.
  • Economic Moats Through Regulation: A material portion of Ingevity’s Performance Materials revenue is anchored in regulatory requirements (e.g., global emission standards), ensuring persistent demand and durable customer relationships.
  • Diversified End-Markets: The company’s chemicals serve a wide array of industries, reducing dependency on any single market or customer. This end-market diversity provides resilience through economic cycles.
  • Supply Chain Integration: Ingevity’s longstanding supplier relationships and vertical integration in the sourcing of renewable feedstocks enable cost-competitive operations and supply reliability.
  • Innovation Capabilities: Ongoing investment in research and development strengthens its product pipeline and supports entry into new applications, sustaining Ingevity’s premium positioning.

🚀 Multi-Year Growth Drivers

Several secular and company-specific factors are poised to support Ingevity’s long-term growth trajectory:
  • Stricter Environmental Standards: Global mandates for lower vehicle emissions, particularly in emerging markets, continue to drive demand for Ingevity’s activated carbon solutions in automotive vapor control.
  • Infrastructure Modernization: Increased government investment in transportation infrastructure and pavement rehabilitation is expected to boost demand for Ingevity’s asphalt additives and adhesion promoters.
  • Growing Focus on Sustainability: Customers increasingly prefer sustainable, bio-based chemicals, aligning with Ingevity’s renewable-based portfolio and creating tailwinds for market expansion.
  • Innovation in Specialty Chemicals: Diversification into higher-value chemical formulations for agriculture, oilfields, and adhesives unlocks new customer segments and improves margin profile.
  • Potential for Geographic Expansion: Penetration into high-growth regions, particularly in Asia-Pacific and Latin America, presents an opportunity to further increase sales and market share.

⚠ Risk Factors to Monitor

Ingevity’s investment thesis is subject to several identifiable risks:
  • Automotive Industry Cyclicality: A considerable share of profits is tied to global automotive production volumes, exposing the company to demand shocks, technological shifts, or regulatory changes favoring alternative propulsion (e.g., electric vehicles).
  • Raw Material Price Volatility: The business relies on renewable feedstocks like crude tall oil. Supply constraints, price spikes, or changes in sourcing economics can pressure margins.
  • Customer Concentration: Although the company serves diverse industries, a limited number of large automotive OEMs account for a significant portion of revenues, increasing counterparty risk.
  • Competitive Pressure: The specialty chemicals and activated carbon markets are competitive, with the potential for technology disruption or share gains by well-capitalized global peers.
  • Regulatory Risk: Evolving government emissions standards or delays in infrastructure funding could impact demand for certain products.

📊 Valuation & Market View

Ingevity is typically valued in the public markets on a blend of earnings, cash flow, and enterprise value multiples, reflecting its stable cash generation and growth profile. Its margins and growth rates are often benchmarked against a peer set that includes specialty chemical and materials manufacturers. Factors influencing market perception include the resiliency of demand from regulated end-markets, ongoing investments in R&D and sustainability, the ability to expand into new regions or product categories, and prudent balance sheet management. Investors and analysts often scrutinize the company’s capital allocation policy — particularly regarding acquisitions, share repurchases, and debt repayment — in the context of free cash flow generation and end-market visibility.

🔍 Investment Takeaway

Ingevity Corporation provides exposure to a diversified mix of specialty chemicals and performance materials with compelling long-term growth drivers rooted in sustainability, regulatory demands, and innovation. The company’s technical and operational strengths, combined with entrenched customer relationships and a proven ability to monetize proprietary formulations, underpin a high-quality business model. Nevertheless, investors should remain vigilant regarding cyclical exposure to automotive demand, input cost fluctuations, and sector competition. For long-term-oriented investors seeking a balanced specialty chemicals company with a focus on environmental performance and consistent value creation, Ingevity offers an attractive, though not risk-free, investment opportunity.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"NGVT reported revenue of $255.1M for the latest quarter, with a net income loss of $84.6M, translating to an EPS of -$2.37. Operating cash flow stood at $97.1M, yielding a free cash flow of $73.5M after accounting for capital expenditures of -$23.6M. The balance sheet reflects total assets of $1.65B and total liabilities of $1.62B, resulting in total equity of $29.7M and net debt of $1.16B. Despite incurring a net loss, NGVT has demonstrated strong operating cash flow. The stock is currently priced at $69.5, with a notable one-year gain of 60.84%, suggesting robust market performance, driven by positive investor sentiment. With a target consensus of $76.67, the outlook remains optimistic. However, the high levels of debt may pose risks if profitability does not improve."

Revenue Growth

Neutral

Revenue of $255.1M indicates growth potential, but ongoing losses could hinder sustainable growth.

Profitability

Neutral

Negative net income and EPS suggest current profitability issues.

Cash Flow Quality

Positive

Strong operating cash flow of $97.1M and positive free cash flow support overall cash generation.

Leverage & Balance Sheet

Caution

High net debt relative to equity indicates financial leverage concerns.

Shareholder Returns

Good

Stock gained 60.84% in the last year, reflecting strong total returns despite no dividends.

Analyst Sentiment & Valuation

Positive

Analyst target consensus of $76.67 suggests room for price appreciation with positive sentiment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Management’s prepared remarks emphasize control of volatility after the Industrial Specialties exit and strong margin/cash generation (gross margin +610 bps, EBITDA margin +500 bps, FCF $274M). However, the Q&A shows the real pressure points are still operational and macro-linked: APT remains hit by indirect tariffs and weak end-demand (sales -15%, EBITDA -18% YoY) and competitive dynamics in China (paint protective film). The company also flagged execution hurdles like $15M stranded costs to be eliminated by year-end (accumulating more in the back half; TSA midyear) and litigation cash outflows (about $95M to BASF in Q2) that reduce flexibility versus headline FCF. Guidance is broadly stable but explicitly assumes no meaningful global recovery, with EPS $4.08–$5.20 and Sales $1.1–$1.2B. Positively, buybacks are positioned as independent of asset-sale proceeds ($300M through 2027), but analysts are clearly probing timing/cadence around both stranded costs and potential APT/Road Markings sales.

AI IconGrowth Catalysts

  • Activated carbon adoption momentum supported by hybrids and fuel-efficient ICE vehicles (Performance Materials)
  • Filtration product optimization: expanding millions of pounds of activated carbon from current base into higher-value separation applications (water, pharma, food & beverage)
  • Road Markings segment: extension of paving season into late fall enabling project catch-up after early-year adverse weather
  • APT productivity and operational discipline to reduce operating costs and stabilize plant production

Business Development

  • Initiated sales processes (announced earlier in December 2025 / ongoing): Advanced Polymer Technologies (APT) and Road Markings product line
  • Completed 1/1/2026 sale of North Charleston CTO refinery and majority of Industrial Specialties product line to 'mainstream pine products' (buyer name not specified)
  • Potential future transaction: divested Industrial Specialties no longer in portfolio; Performance Chemicals re-segmentation into Pavement Technologies and Road Markings

AI IconFinancial Highlights

  • Total company 2025 sales: $1.3B, down 8% YoY (8% decline despite near-record sales momentum in Performance Materials)
  • GAAP net loss: $167M in 2025, including $337M pretax special charges (goodwill impairment $184M in APT; asset impairment $109M in Road Markings)
  • Adjusted gross profit: $556M, up 6.8% YoY; gross margin expanded by +610 bps
  • Total adjusted EBITDA: $398M, up 10% YoY; EBITDA margin expanded by +500 bps to 30.8%
  • Adjusted diluted EPS: +30% YoY to $4.55
  • Performance Materials: revenue $607M flat YoY; EBITDA margin 53.8% (target to maintain >50%)
  • Performance Chemicals (combined continuing): segment EBITDA margin expanded to 13.5% from 4% last year (driven by PC repositioning actions + transition effects + stranded costs)
  • APT: sales down 15% YoY; segment EBITDA 18% lower YoY; held pricing and stable mix; strong EBITDA margin of 20% despite headwinds
  • Free cash flow (FCF): $274M, highest in past 5 years; exceeded updated guidance from Nov; $220M increase from 2024 driven by absence of ~$180M cash outflows related to Performance Chemicals repositioning plus working capital benefit in Industrial Specialties

AI IconCapital Funding

  • Debt/leverage reduction: net leverage reduced to 2.6x (from 3.5x at beginning of 2025; target was <2.8x)
  • Share repurchases: $56M in 2025 for ~1M shares; remaining authorization just under $300M
  • 2026-2027 buybacks: expects $300M of share repurchases through 2027 with ratable cadence
  • 2026 FCF guidance: $225M to $250M; excludes ~$95M pretax litigation-related payments to BASF in Q2

AI IconStrategy & Ops

  • Industrial Specialties divestiture: reported within discontinued operations beginning Q3 2025; completed early Jan 2026 (removes steadier quarterly EBITDA and increases seasonality of Performance Chemicals)
  • PC repositioning actions: lower overall raw materials, supply chain efficiencies, and plant footprint optimization contributing to margin expansion
  • Optimization/automation not explicitly quantified in transcript, but operational discipline/productivity initiatives referenced for APT (reliable plant production; reduced operating costs)
  • Seasonality shift: Performance Chemicals seasonality becomes more prominent after Industrial Specialties removal

AI IconMarket Outlook

  • 2026 guidance (excludes divested Industrial Specialties; includes full year of APT and Road Markings):
  • Adjusted EPS: $4.08 to $5.20 (assuming no meaningful global economy recovery)
  • Sales: $1.1B to $1.2B
  • Adjusted EBITDA: $380M to $400M
  • Performance Materials: low single-digit sales growth; margins consistent with 2025
  • Performance Chemicals (including Road Markings): mid-single-digit sales growth; EBITDA margins in mid-teens
  • APT: flat to low single-digit growth; margins around 20%
  • CapEx: $40M to $60M (consistent with 2025)
  • FCF: $225M to $250M; pay litigation to BASF (~$95M pretax) in Q2 (per guidance)
  • Share repurchases in 2026: already started—repurchased almost $20M in Q1 (per management comment)

AI IconRisks & Headwinds

  • APT: indirect tariffs + weak end-market demand (primarily automotive, footwear, industrial); competitive pressure in China (notably paint protective film); sales -15% YoY; EBITDA -18% YoY
  • Advanced Polymer Technologies: competitive pressure and tariff uncertainty driving disciplined commercial actions and productivity initiatives
  • Performance Materials: lower auto production impacted by tariff uncertainty and supply chain challenges; supply chain disruptions cited (aluminum fire affecting Ford F-150; Honda chip shortages)
  • Road Markings: price pressure from competition (volumes grew slightly)
  • Stranded costs: expects to exit/eliminate $15M by end of year; accumulation over year with more costs in back end; some tied to TSA expected to wrap midyear
  • Asset sale dependence clarification: 2026 outlook does not include proceeds from APT or Road Markings potential sales; buybacks expected regardless of sale proceeds
  • Seasonality risk: after Industrial Specialties removal, ~90% of annual Performance Chemicals EBITDA recognized in Q2-Q3 and 75% of sales in Q2-Q3

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the NGVT Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (NGVT)

© 2026 Stock Market Info — Ingevity Corporation (NGVT) Financial Profile